A sizeable fraction of multiple myeloma (MM) is expected to be explained by heritable
factors. Genome-wide association studies (GWAS) have successfully identified a number of …

Background While genome-wide association studies (GWAS) of multiple myeloma (MM)
have identified variants at 23 regions influencing risk, the genes underlying these …

There is overwhelming epidemiologic evidence that the risk of multiple myeloma (MM) has a
solid genetic background. Genome-wide association studies (GWAS) have identified 23 risk …

The etiology of multiple myeloma (MM) is poorly understood. Summary data from genome-
wide association studies (GWASs) of multiple phenotypes can be exploited in a Mendelian …

Multiple myeloma (MM) is a plasma cell malignancy with a significant heritable basis.
Genome-wide association studies have transformed our understanding of MM …

While the etiology of multiple myeloma (MM) is largely unknown, evidence for an inherited
genetic susceptibility is provided by the two-fold increased risk of the disease seen in first …

Multiple myeloma (MM) is one of the most common hematological malignancies, accounting
for 20% of all newly diagnosed hematological cancers [1]. The most recent data from Cancer …

Genome-wide association studies (GWAS) have transformed our understanding of
susceptibility to multiple myeloma (MM), but much of the heritability remains unexplained …

Multiple myeloma (MM) is the second most common blood malignancy. Epidemiological
family studies going back to the 1920s have provided evidence for familial aggregation …

Background We have engaged in an international program designated the Bank On A Cure,
which has established DNA banks from multiple cooperative and institutional clinical trials …